Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$5.25
+0.0150 (+0.287%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $4.61 $6.10 Friday, 10th May 2024 AFMD stock ended at $5.25. This is 0.287% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 4.28% from a day low at $5.11 to a day high of $5.33.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
Nov 10, 2022 $22.70 $22.90 $20.65 $22.85 278 407
Nov 09, 2022 $23.00 $23.50 $21.00 $21.00 169 340
Nov 08, 2022 $23.90 $25.50 $22.90 $23.40 391 117
Nov 07, 2022 $21.00 $24.75 $20.70 $23.90 560 259
Nov 04, 2022 $20.30 $20.55 $18.30 $19.50 272 715
Nov 03, 2022 $18.80 $21.75 $18.30 $18.50 635 696
Nov 02, 2022 $17.90 $18.00 $16.70 $16.90 173 976
Nov 01, 2022 $17.80 $18.60 $17.60 $18.00 101 685
Oct 31, 2022 $17.50 $17.95 $16.85 $17.60 103 112
Oct 28, 2022 $16.70 $17.75 $16.40 $17.70 97 427
Oct 27, 2022 $16.90 $17.25 $16.20 $16.60 70 326
Oct 26, 2022 $16.50 $17.35 $16.30 $16.60 78 213
Oct 25, 2022 $15.70 $16.75 $15.45 $16.50 89 061
Oct 24, 2022 $16.50 $16.50 $15.24 $15.50 84 858
Oct 21, 2022 $15.30 $16.60 $14.90 $16.60 122 613
Oct 20, 2022 $14.90 $16.10 $14.50 $15.20 98 948
Oct 19, 2022 $15.20 $15.40 $14.60 $14.80 83 158
Oct 18, 2022 $15.90 $16.35 $15.10 $15.50 92 178
Oct 17, 2022 $15.70 $16.05 $15.20 $15.50 124 760
Oct 14, 2022 $15.20 $15.70 $15.00 $15.20 150 481
Oct 13, 2022 $14.30 $16.10 $14.20 $15.60 137 483
Oct 12, 2022 $15.70 $15.80 $14.00 $15.00 290 483
Oct 11, 2022 $15.50 $16.10 $14.60 $15.60 235 836
Oct 10, 2022 $18.30 $18.40 $15.60 $15.90 330 141
Oct 07, 2022 $19.70 $19.80 $19.00 $19.00 75 654
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT